First human test for new celiac disease detection method
Diagnosis
Not yet recruiting
This early-stage study is testing the safety of a single dose of a new oral diagnostic agent called HB-2121 in adults who are already scheduled for a standard celiac disease scope test. The main goal is to see what side effects participants experience and how the agent interacts …
Phase: PHASE1 • Sponsor: Nielsen Fernandez-Becker • Aim: Diagnosis
Last updated Mar 30, 2026 14:30 UTC